Functionnal and mitochondrial dynamics alterations in patients with chronic hepatitis B and advanced fibrosis

被引：0
|
作者：
Loureiro, Dimitri [1 ,2 ]
Tout, Issam [1 ,2 ]
Bed, Cheikh Mohemed [1 ,2 ]
Roinard, Morganer [1 ,2 ]
Sleiman, Ahmad [1 ,2 ]
Nathalie, Boyer [1 ,2 ]
Narguet, Stephanie [1 ,2 ]
Pons-Kerjean, Nathalie [2 ,3 ]
Castelnau, Corinne [1 ,2 ]
Giuly, Nathalie [1 ,2 ]
Soumelis, Vassili [4 ]
El Benna, Jamel [2 ]
Soussan, Patrick [5 ]
Moreau, Richard [2 ]
Paradis, Valerie [2 ]
Mansouri, Abdel [1 ,2 ]
Asselah, Tarik [1 ,2 ]
机构：
[1] Hosp Beaujon, AP HP, Hepatol, Clichy, France
[2] Ctr Rech Inflammat, U1149, Paris, France
[3] Hosp Beaujon, AP HP, Pharm, Clichy, France
[4] Hosp St Louis, Lab Immunol & Histocompatibilit, Paris, France
[5] Paris Diderot Univ, U1135, Paris, France
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU304
引用
收藏
页码：S245 / S246
页数：2
相关论文
共 50 条
  • [31] Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients
    Wang, Bingqiong
    Sun, Yameng
    Zhou, Jialing
    Wu, Xiaoning
    Chen, Shuyan
    Wu, Shanshan
    Liu, Hui
    Wang, Tailing
    Ou, Xiaojuan
    Ha, Jidong
    You, Hong
    MODERN PATHOLOGY, 2018, 31 (10) : 1567 - 1577
  • [32] MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C
    Kevin Appourchaux
    Safi Dokmak
    Matthieu Resche-Rigon
    Xavier Treton
    Martine Lapalus
    Charles-Henry Gattolliat
    Emmanuelle Porchet
    Michelle Martinot-Peignoux
    Nathalie Boyer
    Michel Vidaud
    Pierre Bedossa
    Patrick Marcellin
    Ivan Bièche
    Emilie Estrabaud
    Tarik Asselah
    Scientific Reports, 6
  • [33] Larger biopsies evaluation of transient elastography for detecting advanced fibrosis in patients with compensated chronic hepatitis B
    Chen, Yong Peng
    Liang, Xie Er
    Zhang, Qi
    Peng, Jie
    Zhu, You Fu
    Wen, Wei Qun
    Hou, Jin Lin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (07) : 1219 - +
  • [34] Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B
    Wong, Sui-Weng
    Chan, Wah-Kheong
    Mohamed, Rosmawati
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (12) : 1297 - 1305
  • [35] Commentary: triple therapy for patients with chronic hepatitis C and advanced fibrosis?
    Ferenci, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (11-12) : 1407 - 1408
  • [36] Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B
    Masaru Enomoto
    Hiroyasu Morikawa
    Akihiro Tamori
    Norifumi Kawada
    World Journal of Gastroenterology, 2014, (34) : 12031 - 12038
  • [37] APRI is not a Useful Predictor of Fibrosis for Patients with Chronic Hepatitis B
    Mamun-Al-Mahtab
    Shrestha, Ananta
    Rahman, Salimur
    Khan, Mobin
    Kamal, Mohammad
    HEPATITIS MONTHLY, 2009, 9 (03) : 185 - 188
  • [38] Models to predict inflammation and fibrosis in patients with chronic hepatitis B
    Lok, A
    Goodman, Z
    Marcellin, P
    Hadziyannis, S
    Hudson, S
    Currie, G
    Brosgart, CL
    JOURNAL OF HEPATOLOGY, 2004, 40 : 129 - 129
  • [39] Effects of heparin on liver fibrosis in patients with chronic hepatitis B
    Jun Shi Jing-Hua Hao Wan-Hua Ren Ju-Ren Zhu
    World Journal of Gastroenterology, 2003, 9 (07) : 1611 - 1614
  • [40] Biomarkers of Fibrosis in Low Replicative Chronic Hepatitis B Patients
    Sanai, Faisal M.
    Farah, Taha
    Albeladi, Khalid
    Batwa, Faisal
    Dahlan, Yaser
    Babatin, Mohammed A.
    Al-Ashgar, Hamad I.
    Al-Mana, Hadeel
    Alsaad, Khaled
    Alswat, Khalid A.
    Aljumah, Abdulrahman A.
    Altraif, Ibrahim H.
    Bzeizi, Khalid I.
    HEPATOLOGY, 2015, 62 : 993A - 994A
12345